Fucoidans Disrupt Adherence of Helicobacter pylori to AGS Cells In Vitro
Eng-Guan Chua1, Phebe Verbrugghe1, Timothy T Perkins1
1The Marshall Centre for Infectious Diseases Research and Training, School of Pathology and Laboratory Medicine (M502), The University of Western Australia, 35 Stirling Highway, Nedlands, WA 6009, Australia.
Abstract:
Fucoidans are complex sulphated polysaccharides derived from abundant and edible marine algae. Helicobacter pylori is a stomach pathogen that persists in the hostile milieu of the human stomach unless treated with antibiotics. This study aims to provide preliminary data to determine, in vitro, if fucoidans can inhibit the growth of H. pylori and its ability to adhere to gastric epithelial cells (AGS). We analysed the activity of three different fucoidan preparations (Fucus A, Fucus B, and Undaria extracts). Bacterial growth was not arrested or inhibited by the fucoidan preparations supplemented into culture media. All fucoidans, when supplemented into tissue culture media at 1000 µg mL(-1), were toxic to AGS cells and reduced the viable cell count significantly. Fucoidan preparations at 100 µg mL(-1) were shown to significantly reduce the number of adherent H. pylori. These in vitro findings provide the basis for further studies on the clinical use of sulphated polysaccharides as complementary therapeutic agents.
Insights
Fucoidans, derived from marine algae, did not inhibit Helicobacter pylori growth but reduced its adhesion to stomach cells in vitro. Further research is suggested for their clinical use.
Area of Science:
- Marine natural products
- Microbiology
- Cell biology
Background:
- Fucoidans are complex sulfated polysaccharides from marine algae.
- Helicobacter pylori is a significant gastric pathogen requiring antibiotic treatment.
- Investigating natural compounds for anti-H. pylori activity is crucial.
Purpose of the Study:
- To evaluate the in vitro efficacy of fucoidans against Helicobacter pylori.
- To determine if fucoidans inhibit H. pylori growth and adhesion to gastric cells.
- To assess the safety of fucoidans on gastric epithelial cells.
Main Methods:
- Three fucoidan extracts (Fucus A, Fucus B, Undaria) were tested.
- Bacterial growth inhibition assays were performed.
- Adhesion assays using gastric epithelial cells (AGS) were conducted.
- Cytotoxicity of fucoidans on AGS cells was evaluated.
Main Results:
- Fucoidans did not inhibit H. pylori growth in culture media.
- High concentration (1000 µg/mL) fucoidans were toxic to AGS cells.
- Lower concentration (100 µg/mL) fucoidans significantly reduced H. pylori adhesion to AGS cells.
Conclusions:
- Fucoidans show potential in reducing H. pylori adhesion to gastric cells.
- Fucoidans may serve as complementary agents in H. pylori management.
- Further in vitro and in vivo studies are warranted to explore clinical applications.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Gene Regulation in Microbial Communities: Quorum Sensing


